{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:43:03Z","timestamp":1793133783844,"version":"4.5.0"},"reference-count":35,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,7,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Few large, international series of enteropathy-associated T-cell lymphoma (EATL) have been reported. We studied a cohort of 62 patients with EATL among 1153 patients with peripheral T-cell or natural killer (NK)\u2013cell lymphoma from 22 centers worldwide. The diagnosis was made by a consensus panel of 4 expert hematopathologists using World Health Organization (WHO) criteria. Clinical correlations and survival analyses were performed. EATL comprised 5.4% of all lymphomas in the study and was most common in Europe (9.1%), followed by North America (5.8%) and Asia (1.9%). EATL type 1 was more common (66%) than type 2 (34%), and was especially frequent in Europe (79%). A clinical diagnosis of celiac sprue was made in 32.2% of the patients and was associated with both EATL type 1 and type 2. The median overall survival was only 10 months, and the median failure-free survival was only 6 months. The International Prognostic Index (IPI) was not as good a predictor of survival as the Prognostic Index for Peripheral T-Cell Lymphoma (PIT). Clinical sprue predicted for adverse survival independently of the PIT. Neither EATL subtype nor other biologic parameters accurately predicted survival. Our study confirms the poor prognosis of patients with EATL and the need for improved treatment options.<\/jats:p>","DOI":"10.1182\/blood-2011-02-335216","type":"journal-article","created":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T05:22:28Z","timestamp":1305264148000},"page":"148-155","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":297,"title":["Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project"],"prefix":"10.1182","volume":"118","author":[{"given":"Jan","family":"Delabie","sequence":"first","affiliation":[{"name":"Departments of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Holte","sequence":"additional","affiliation":[{"name":"Oncology, University Hospital of Oslo, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Vose","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Ullrich","sequence":"additional","affiliation":[{"name":"College of Public Health, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Institute, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry J.","family":"Savage","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Connors","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rimsza","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Arizona, Tucson, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"M\u00fcller-Hermelink","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"R\u00fcdiger","sequence":"additional","affiliation":[{"name":"Institute of Pathology, St\u00e4dtisches Klinikum Karlsruhe, Karlsruhe, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Coiffier","sequence":"additional","affiliation":[{"name":"Department of Hematology, Centre Hospitalier Lyon-Sud, Lyon, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy D.","family":"Gascoyne","sequence":"additional","affiliation":[{"name":"Department of Pathology, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Pathology, Centre Hospitalier Lyon-Sud, Lyon, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensei","family":"Tobinai","sequence":"additional","affiliation":[{"name":"Hematology and Stem cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Y.","family":"Au","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hong Kong, Hong Kong, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hong Kong, Hong Kong, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emili","family":"Montserrat","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Oncology, University of Barcelona Hospital, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephraim P.","family":"Hochberg","sequence":"additional","affiliation":[{"name":"Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pileri","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Bologna Hospital, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Federico","sequence":"additional","affiliation":[{"name":"Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Nathwani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cedars Sinai Medical Center and University of Southern California Keck School of Medicine, Los Angeles, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D.","family":"Weisenburger","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111807444086100_B1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/gut.3.3.232","article-title":"Intestinal reticulosis as a complication of idiopathic steatorrhea.","volume":"3","author":"Gough","year":"1962","journal-title":"Gut"},{"issue":"8","key":"2019111807444086100_B2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/gut.17.8.612","article-title":"Coeliac disease, gluten-free diet, and malignancy.","volume":"17","author":"Holmes","year":"1976","journal-title":"Gut"},{"issue":"8055","key":"2019111807444086100_B3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(78)90004-1","article-title":"Intestinal lymphoma associated with malabsorption.","volume":"1","author":"Isaacson","year":"1978","journal-title":"Lancet"},{"issue":"8316","key":"2019111807444086100_B4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(83)91754-3","article-title":"Coeliac disease and malignancy.","volume":"1","author":"Swinson","year":"1983","journal-title":"Lancet"},{"issue":"1","key":"2019111807444086100_B5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.7326\/0003-4819-104-1-44","article-title":"T-cell intestinal lymphoma associated with celiac sprue.","volume":"104","author":"Loughran","year":"1986","journal-title":"Ann Intern Med"},{"issue":"6552","key":"2019111807444086100_B6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/bmj.293.6552.908","article-title":"Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma.","volume":"293","author":"O'Farrelly","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"2019111807444086100_B7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-199509000-00012","article-title":"Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era.","volume":"21","author":"Egan","year":"1995","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"2019111807444086100_B8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0002-9610(98)00193-7","article-title":"Gastrointestinal malignancies in patients with celiac sprue.","volume":"176","author":"Pricolo","year":"1998","journal-title":"Am J Surg"},{"issue":"1","key":"2019111807444086100_B9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/gut.2003.032094","article-title":"Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma.","volume":"54","author":"Smedby","year":"2005","journal-title":"Gut"},{"key":"2019111807444086100_B10","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1053\/j.gastro.2005.02.027","article-title":"Association of celiac disease and intestinal lymphomas and other cancers.","volume":"128","author":"Catassi","year":"2005","journal-title":"Gastroenterology"},{"issue":"11","key":"2019111807444086100_B11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/00365520802240222","article-title":"Incidence of enteropathy-associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands.","volume":"43","author":"Verbeek","year":"2008","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"2019111807444086100_B12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bpg.2009.11.002","article-title":"Enteropathy associated T-cell lymphoma and its precursor lesions.","volume":"24","author":"van de Water","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"2019111807444086100_B13","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0002-9440(10)65736-7","article-title":"Most CD56+ intestinal lymphomas are CD8+, CD5- T-cell lymphomas of monomorphic small to medium size morphology.","volume":"153","author":"Chott","year":"1998","journal-title":"Am J Pathol"},{"issue":"5","key":"2019111807444086100_B14","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","article-title":"Chromosomal Gains at 9q characterize enteropathy-type T-cell lymphoma.","volume":"161","author":"Zettl","year":"2002","journal-title":"Am J Pathol"},{"issue":"10","key":"2019111807444086100_B15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/01.LAB.0000090157.13040.58","article-title":"High frequency of genetic aberrations in enteropathy-type T-cell lymphoma.","volume":"83","author":"Baumg\u00e4rtner","year":"2003","journal-title":"Lab Invest"},{"issue":"5","key":"2019111807444086100_B16","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes.","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"2019111807444086100_B17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1703","article-title":"Gastrointestinal lymphoma: where morphology meets molecular biology.","volume":"205","author":"Isaacson","year":"2005","journal-title":"J Pathol"},{"issue":"10","key":"2019111807444086100_B18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1440-1827.2008.02281.x","article-title":"CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.","volume":"58","author":"Akiyama","year":"2008","journal-title":"Pathol Int"},{"issue":"8","key":"2019111807444086100_B19","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/PAS.0b013e3181a95c63","article-title":"NK-cell lineage predicts poor survival in primary intestinal NK-cell and T-cell lymphomas.","volume":"33","author":"Chuang","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"2019111807444086100_B20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.humpath.2009.11.020","article-title":"Enteropathy-associated T-cell lymphoma \u2013 a clinicopathologic and array comparative genomic hybridization study.","volume":"41","author":"Ko","year":"2010","journal-title":"Hum Pathol"},{"issue":"25","key":"2019111807444086100_B21","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International T-cell lymphoma project. International Peripheral T-cell Lymphoma Project: International peripheral T-cell and NK\/T-cell lymphoma study: pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"2019111807444086100_B22","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"2019111807444086100_B23","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"13","key":"2019111807444086100_B24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bpg.2005.02.006","article-title":"Diagnosis of coeliac disease.","volume":"19","author":"Green","year":"2005","journal-title":"Best Pract Res Gastroenterol"},{"issue":"282","key":"2019111807444086100_B25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"2019111807444086100_B26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"issue":"14","key":"2019111807444086100_B27","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma.","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111807444086100_B28","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2019111807444086100_B29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center.","volume":"18","author":"Gale","year":"2000","journal-title":"J Clin Oncol"},{"issue":"18","key":"2019111807444086100_B30","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2009-07-231324","article-title":"Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.","volume":"115","author":"Sieniawski","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111807444086100_B31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0609.2005.00495.x","article-title":"Clinicopathological analysis of T-cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy-type intestinal T-cell lymphoma.","volume":"75","author":"Lee","year":"2005","journal-title":"Eur J Haematol"},{"issue":"4","key":"2019111807444086100_B32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MPG.0b013e31812e5710","article-title":"Ninety percent of celiac disease is being missed.","volume":"45","author":"Ravikumara","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"2019111807444086100_B33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.287.11.1413","article-title":"Italian Working Group on Coeliac Disease and Non-Hodgkin' s-Lymphoma. Risk of non Hodgkin lymphoma in celiac disease.","volume":"287","author":"Catassi","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"2019111807444086100_B34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00042737-200602000-00012","article-title":"Biomed Study Group on Coeliac Disease and Non-Hodgkin Lymphoma. European multi-centre study on coeliac disease and non-Hodgkin lymphoma.","volume":"18","author":"Mearin","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"2019111807444086100_B35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/gut.2003.032094","article-title":"Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma.","volume":"54","author":"Smedby","year":"2005","journal-title":"Gut"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/1\/148\/1340372\/zh802711000148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/1\/148\/1340372\/zh802711000148.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:35:32Z","timestamp":1741185332000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/1\/148\/28418\/Enteropathyassociated-Tcell-lymphoma-clinical-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7,7]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-02-335216","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,7]]}}}